Retraction Note: Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway

Affiliations

• ¹ Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 20003, China.
• ² Department of Respiration, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China.
• ³ Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China.
• ⁴ Shanghai Respiratory Research Institute, Shanghai, 20003, China.
• ⁵ State Key Laboratory of Bioreactor Engineering & Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, People's Republic of China.
• ⁶ Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China.
• ⁷ Department of Respiration, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China. [email protected].
• ⁸ Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China. [email protected].
• ⁹ Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 20003, China. [email protected].
• ¹⁰ Shanghai Respiratory Research Institute, Shanghai, 20003, China. [email protected].
• ¹¹ Department of Pulmonary Medicine, Zhongshan Hospital, Qingpu Branch, Fudan University, Shanghai, 201700, China. [email protected].
• ¹² National Clinical Research Center for Aging & Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China. [email protected].